STORRS, Conn. – The top-seeded and third-ranked UConn women's basketball team (28-3, 18-0 BIG EAST) takes on eighth-seeded St. John's (16-14, 5-13) in the BIG EAST Tournament quarterfinals ...

Paige Bueckers won Big East Player of the Year for the third time, leading a sweep of the conference's major awards Thursday by UConn. The third-ranked Huskies went 18-0 in the Big East and ...

Why is that? How is it that even radical innovation might not threaten incumbent companies? To understand how “Big Pharma” can stay on top, we can look at the example of the mRNA vaccines. The ...

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79% The IRA, however, presents a different challenge. Merck has already had two drugs picked for the yearly list of ...

Instead of helping low-income countries get the vaccines they need, Justin Trudeau is protecting big pharma’s profits by blocking countries’ ability to produce cheaper vaccines OTTAWA – On Friday, NDP ...

Pakistan Single Window (PSW) CEO Syed Aftab Haider has said that digitalisation of regulatory processes will simplify compliance requirement and help pharmaceutical firms to reduce the time and ...

Gland Pharma Ltd on Tuesday (February 25) announced that America's drug regulatory watchdog has completed a crucial inspection of its Andhra Pradesh facility. In a regulatory filing, Gland Pharma said ...

In his first three weeks, President Trump has pushed the government’s checks and balances designed to limit executive power. Here’s a look at how the system works, what’s happening now, and ...

Its time for Indian pharma companies to look beyond the U.S. market as the Trump administration has threatened to impose 25% tariff on pharmaceutical imports. This move would disrupt India’s ...

The federal government under the Trump administration has turned its focus to cutting costs, and a new report from the Blue Cross Blue Shield Association highlights policy efforts it says could ...

“Obesity is the market everybody wants to look at, it's a very, very big market opening up…we are no exception to that," Atish Majumdar, senior president at Mankind Pharma, told Mint.